MiR‐126 enhances the VEGF‐induced angiogenesis in SSc‐MVECs by targeting SPRED1 and PIK3R2, which are the negative regulator of Raf‐ERK and PI3K‐AKT signalling separately. Here, RAF1 is linked to systemic sclerosis.